Adverum Biotechnologies, Inc. (ADVM)
NASDAQ: ADVM · Real-Time Price · USD
6.17
-0.08 (-1.28%)
Nov 20, 2024, 4:00 PM EST - Market closed

Adverum Biotechnologies Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Revenue
13.6-7.5-0.25
Upgrade
Revenue Growth (YoY)
-72.22%-----84.49%
Upgrade
Cost of Revenue
68.2277.6895.5889.1873.3140.42
Upgrade
Gross Profit
-67.22-74.08-95.58-81.68-73.31-40.17
Upgrade
Selling, General & Admin
35.6549.6954.7363.3844.6428.38
Upgrade
Operating Expenses
35.6549.6954.7363.3844.6428.38
Upgrade
Operating Income
-102.88-123.77-150.31-145.06-117.95-68.55
Upgrade
Interest & Investment Income
7.865.752.670.581.564.06
Upgrade
EBT Excluding Unusual Items
-95.02-118.02-147.64-144.48-116.39-64.49
Upgrade
Merger & Restructuring Charges
---4.7---
Upgrade
Asset Writedown
-0.22-0.22-2.12-1.06--
Upgrade
Pretax Income
-95.24-118.24-154.46-145.54-116.39-64.49
Upgrade
Income Tax Expense
-1.13-1.080.07-1.11-
Upgrade
Net Income
-94.11-117.17-154.54-145.54-117.51-64.49
Upgrade
Net Income to Common
-94.11-117.17-154.54-145.54-117.51-64.49
Upgrade
Shares Outstanding (Basic)
1710101096
Upgrade
Shares Outstanding (Diluted)
1710101096
Upgrade
Shares Change (YoY)
70.02%1.58%1.24%15.14%32.83%4.44%
Upgrade
EPS (Basic)
-5.51-11.62-15.57-14.85-13.80-10.06
Upgrade
EPS (Diluted)
-5.51-11.62-15.57-14.85-13.80-10.06
Upgrade
Free Cash Flow
-86.06-91.71-119.91-122.95-91.14-68.42
Upgrade
Free Cash Flow Per Share
-5.04-9.10-12.08-12.54-10.70-10.67
Upgrade
Operating Margin
-10287.60%-3437.97%--1934.12%--27418.00%
Upgrade
Profit Margin
-9411.10%-3254.58%--1940.53%--25794.40%
Upgrade
Free Cash Flow Margin
-8606.00%-2547.50%--1639.39%--27366.80%
Upgrade
EBITDA
-99.02-118.12-143.78-140.41-113.79-66.97
Upgrade
D&A For EBITDA
3.855.646.534.654.161.57
Upgrade
EBIT
-102.88-123.77-150.31-145.06-117.95-68.55
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.